Investigating Human Host Factors Involved in Coronavirus Infection in the Search for Antivirals

Grant number: 224917/Z/21/Z

Grant search

Key facts

  • Disease

    COVID-19, Unspecified
  • Start & end year

    2021
    2024
  • Known Financial Commitments (USD)

    $0
  • Funder

    Wellcome Trust
  • Principal Investigator

    Miss. Holly Kerr
  • Research Location

    United Kingdom
  • Lead Research Institution

    University of Edinburgh
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

SARS-CoV-2 is the virus that causes COVID-19 in humans and has resulted in a global pandemic since March 2020. Viruses are small pathogens that need to find, bind and enter host cells to replicate and assemble new virus particles that are then released to infect neighbouring cells or other hosts. This project aims to find parts of the human cell (known as host factors) that are involved in SARS-CoV-2 infection. I will continue research from a large experiment which will identify host factors that either help or hinder the virus. We can then use drugs to either inhibit that which helps the virus (pro-viral factors), or promote that which fights the virus (anti-viral factors) to develop antiviral therapies for the treatment of COVID-19. Drugs with potential antiviral activity in cell models may then be moved to preclinical mouse models to test if they work against SARS-CoV-2 infection and are safe. I will also assess if any drug targets are translatable to other coronavirus infections. Finding drugs that act against a broad range of coronaviruses may be important in the event of a new, infectious coronavirus outbreak in future.